Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited
Your view on FPH.AX
Overview
What the company does, where it operates, and who runs it.
About Fisher & Paykel Healthcare Corporation Limited
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Lewis G. Gradon
- Headquarters
- 15 Maurice Paykel Place, Auckland, AUK, NZ
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Lewis G. Gradon
- Headquarters
- 15 Maurice Paykel Place, Auckland, AUK, NZ
Fisher & Paykel Healthcare Corporation Limited, operating with its various subsidiaries, is a global innovator in medical device technology. The company specializes in the design, production, and worldwide distribution of sophisticated products and systems. These solutions primarily cater to acute and chronic respiratory care, support during surgical procedures, and the treatment of obstructive sleep apnea (OSA) in both clinical settings and home environments. Their product lineup includes notable items such as the Airvo 2, a humidified nasal high flow system; Optiflow, designed for nasal high flow therapy; and the F&P 850 System, which offers both non-invasive and invasive ventilation capabilities. For infant care, the company supplies respiratory products used in resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Hospital-grade offerings comprise humidification devices, breathing circuits, chambers, diverse masks, nasal cannulas, surgical accessories, and various interfaces. For homecare users, Fisher & Paykel provides masks, CPAP devices, data management software, humidifiers, and complementary accessories. Established in 1934, the company maintains its headquarters in Auckland, New Zealand.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Fisher & Paykel Healthcare Corporation Limited, and the rating behind it. FPH.AX last traded at AUD 34.94, 53.9× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Fisher & Paykel Healthcare Corporation Limited. Starting points for Fisher & Paykel Healthcare Corporation Limited: P/E 53.9, EPS AUD 0.67, beta 0.89 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Fisher & Paykel Healthcare Corporation Limited. Fisher & Paykel Healthcare Corporation Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Fisher & Paykel Healthcare Corporation Limited. Trailing twelve-month EPS for Fisher & Paykel Healthcare Corporation Limited stands at AUD 0.67. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Fisher & Paykel Healthcare Corporation Limited. Fisher & Paykel Healthcare Corporation Limited has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Fisher & Paykel Healthcare Corporation Limited valued side by side against its closest peers. Fisher & Paykel Healthcare Corporation Limited is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Fisher & Paykel Healthcare Corporation Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Fisher & Paykel Healthcare Corporation Limited executives and directors. Shares of Fisher & Paykel Healthcare Corporation Limited have traded between AUD 26.51 and AUD 35.31 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Fisher & Paykel Healthcare Corporation Limited. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Fisher & Paykel Healthcare Corporation Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Fisher & Paykel Healthcare Corporation Limited. Coverage tracks Fisher & Paykel Healthcare Corporation Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.